Skip to content
Search

Latest Stories

Independent pharmacies led Covid vaccination drive, NPA research reveals

Independent pharmacies played a leading role in administering Covid-19 vaccines in the country, latest data compiled by the National Pharmacy Association has revealed.

According to the latest research conducted by the NPA and PharmData, independent community pharmacies were the biggest deliverers of Covid vaccines during January - September 2021 as compared to corporate-run pharmacy sites.


The PharmData figures which looked at 610 pharmacy sites around the country showed that 85 per cent of them were independents, most of whom are NPA members.

NPA chief executive Mark Lyonette said: “These figures show us that flexible, locally engaged, entrepreneurial independent community pharmacies are making a huge contribution to the vaccine programme.

“Our members have been a shining example of going above and beyond in the most challenging of circumstances to provide millions of Covid jabs, including boosters. Looking further forward, pharmacies will probably still be protecting people long after the mass vaccination centres have been wound down.”

A spokesperson from PharmData said: “This analysis shows the power of numbers to tell stories about how community pharmacies are delivering for the nation. The data present a compelling picture of the great things pharmacies do.”

Latest figures indicate that the total number of Covid jabs delivered by pharmacies up to September were 11.4 million.

As of January 2022, pharmacies across the whole sector had delivered 22 million Covid jabs, including a third of all booster jabs.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less